Sensitization on Hemodialysis After Renal Graft Failure: HLA Incompatibility Still Matters
Transplantation Proceedings · 2025
DOI: 10.1016/j.transproceed.2024.11.032 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Transplantation Proceedings, 2025. Verfasst von Mar Huelva-López und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Reina Sofía University Hospital, Cordoba, Spain. Electronic address: marhuelva45@gmail.com. Hauptthemen laut MEDLINE: Renal Dialysis, HLA Antigens, Kidney Transplantation, Graft Rejection. Die Arbeit nennt 7 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Nephrology, Reina Sofía University Hospital, Cordoba, Spain. Electronic address: marhuelva45@gmail.com.
- Department of Nephrology, Reina Sofía University Hospital, Cordoba, Spain.
Zitieren
APA
Huelva-López, M., Ciudad-Montejo, M., Novillo-Sarmiento, C. F., Moyano-Peregrín, C., García-Montemayor, V. E., Ojeda-López, R., Agüera-Morales, M. L., & Rodríguez-Benot, A. (2025). Sensitization on Hemodialysis After Renal Graft Failure: HLA Incompatibility Still Matters. Transplantation Proceedings. https://doi.org/10.1016/j.transproceed.2024.11.032
Vancouver
Huelva-López M, Ciudad-Montejo M, Novillo-Sarmiento CF, Moyano-Peregrín C, García-Montemayor VE, Ojeda-López R, et al. Sensitization on Hemodialysis After Renal Graft Failure: HLA Incompatibility Still Matters. Transplantation Proceedings. 2025. doi:10.1016/j.transproceed.2024.11.032
BibTeX
@article{HuelvaLpez2025,
author = {Huelva-López, Mar and Ciudad-Montejo, Marta and Novillo-Sarmiento, Carlos Fernando and Moyano-Peregrín, Cayetana and García-Montemayor, Victoria Eugenia and Ojeda-López, Raquel and Agüera-Morales, María Luisa and Rodríguez-Benot, Alberto},
title = {Sensitization on Hemodialysis After Renal Graft Failure: HLA Incompatibility Still Matters},
journal = {Transplantation Proceedings},
year = {2025},
doi = {10.1016/j.transproceed.2024.11.032}
}
EUVIMED